Additional file 2: of Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma
Meng‐Xin Tian(Sun Yat-sen University), Ying–Hong Shi(Ministry of Education of the People's Republic of China), Pei‐Yun Zhou(Fudan University), Wei‐Feng Qu(Ministry of Education of the People's Republic of China), Wei‐Ren Liu(Chung Yuan Christian University), Yuan Fang, Wan Yee Lau(Chinese University of Hong Kong), Zhi Dai(Ministry of Education of the People's Republic of China), Jian Zhou(Shenzhen University Health Science Center), Chenyang Tao(Ministry of Education of the People's Republic of China), Shuang–Jian Qiu(Fudan University), Han Wang(Hebei Agricultural University), Lei Jin(Air Force Medical University), Jia Fan(Fudan University), Zheng Tang(Wuhan University), Xi‐Fei Jiang(Sun Yat-sen University), Zhen‐Bin Ding(Fudan University), Yufu Zhou(Central South University), Yuan‐Fei Peng(Fudan University)
Cited by 0
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828